Endocrinology, Vol 127, 46-54, Copyright © 1990 by Endocrine Society

ARTICLES

Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha

C Grunfeld, M Soued, S Adi, AH Moser, CA Dinarello and KR Feingold
Department of Medicine, University of California, San Francisco.

Tumor necrosis factor (TNF) increases serum triglycerides in rats by increasing de novo hepatic fatty acid synthesis and very low density lipoprotein production. We have recently shown that several other cytokines increase hepatic fatty acid synthesis in the mouse. We now explore the mechanism by which these cytokines increase de novo lipogenesis and the interactions between cytokines in fed mice. TNF administration results in increased hepatic levels of citrate, the primary allosteric activator of acetyl-CoA carboxylase, which is the major rate-limiting enzyme for fatty acid synthesis. The TNF-induced increase in citrate occurs within 15 min of administration, early enough to account for the acute rise in hepatic fatty acid synthesis seen by 30 min after TNF administration. IL-1, which also increases hepatic fatty acid synthesis, produces similar increases in hepatic citrate levels. In contrast, another potent stimulator of hepatic fatty acid synthesis, interferon-alpha (IFN alpha), has no effect on hepatic citrate levels. There were no acute effects of TNF or IL-1 on the activation state of acetyl-CoA carboxylase. A trend toward an increase in the activation state of acetyl-CoA carboxylase was seen after IFN alpha administration. Low doses of TNF and IL-1 given in combination show no synergy while maximal doses are not additive. In contrast, when a low dose of either TNF or IL-1 is combined with a low dose of IFN alpha, there is synergy in stimulating hepatic fatty acid synthesis. A maximal dose of TNF or IL-1 and a high dose of IFN alpha produce a further increase in hepatic fatty acid synthesis. These data support the concept that there are two classes of cytokines that stimulate hepatic fatty acid synthesis, those that can increase hepatic citrate levels and those that cannot.

This article has been cited by other articles:

				C. Popa, M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk J. Lipid Res., April 1, 2007; 48(4): 751 - 762. [Abstract] [Full Text] [PDF]

				W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]

				G. W. TAYLOR The effects of periodontal treatment on diabetes J Am Dent Assoc, October 1, 2003; 134(suppl_1): 41S - 48S. [Abstract] [Full Text] [PDF]

				J. F. FRIEDMAN, P. A. PHILLIPS-HOWARD, W. A. HAWLEY, D. J. TERLOUW, M. S. KOLCZAK, M. BARBER, N. OKELLO, J. M. VULULE, C. DUGGAN, B. L. NAHLEN, et al. IMPACT OF PERMETHRIN-TREATED BED NETS ON GROWTH, NUTRITIONAL STATUS, AND BODY COMPOSITION OF PRIMARY SCHOOL CHILDREN IN WESTERN KENYA Am J Trop Med Hyg, April 1, 2003; 68(90040): 78 - 85. [Abstract] [Full Text] [PDF]

				J. M.W. Geurts, R. G.J.H. Janssen, M. M.J. van Greevenbroek, C. J.H. van der Kallen, R. M. Cantor, X.-d. Bu, B. E. Aouizerat, H. Allayee, J. I. Rotter, and T. W.A. de Bruin Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia Hum. Mol. Genet., September 1, 2000; 9(14): 2067 - 2074. [Abstract] [Full Text] [PDF]

				S. M. Cohen, J. G. Werrmann, and M. R. Tota 13C NMR study of the effects of leptin treatment on kinetics of hepatic intermediary metabolism PNAS, June 23, 1998; 95(13): 7385 - 7390. [Abstract] [Full Text] [PDF]

				J. L. Funk, A. H. Moser, C. Grunfeld, and K. R. Feingold Parathyroid Hormone-Related Protein Is Induced in the Adult Liver during Endotoxemia and Stimulates the Hepatic Acute Phase Response Endocrinology, July 1, 1997; 138(7): 2665 - 2673. [Abstract] [Full Text] [PDF]